MedTrace Logo

Gellan Contact Study

NCT04044014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2019-08-02

No results posted yet for this study

Summary

The primary objective of this study will be to establish the safety of the two different Gellan formulations (sheet and fluid gel) following its application to the epidermis of healthy volunteers. This will be compared to a control dressing-- Mepitel One (Polyurethane net with soft Silicone).

Conditions

  • Thermal Injury
  • Skin Burn

Interventions

DEVICE

Gellan sheet

Gellan sheet.

DEVICE

Gellan fluid gel

Gellan fluid gel.

DEVICE

Mepitel One

Control dressing-- Mepitel One.

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • University Hospital Birmingham

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-10
Primary Completion
2017-02-13
Completion
2017-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04044014 on ClinicalTrials.gov